Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

240 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
ERG alterations and mTOR pathway activation in primary prostate carcinomas developing castration-resistance.
Vicentini C, Cantù C, Antonello D, Simbolo M, Mafficini A, Luchini C, Rusev B, Porcaro AB, Iacovelli R, Fassan M, Corbo V, Brunelli M, Artibani W, Scarpa A, Lawlor RT. Vicentini C, et al. Among authors: iacovelli r. Pathol Res Pract. 2018 Oct;214(10):1675-1680. doi: 10.1016/j.prp.2018.08.031. Epub 2018 Aug 29. Pathol Res Pract. 2018. PMID: 30190183 Free article.
The prospect of precision therapy for renal cell carcinoma.
Ciccarese C, Brunelli M, Montironi R, Fiorentino M, Iacovelli R, Heng D, Tortora G, Massari F. Ciccarese C, et al. Among authors: iacovelli r. Cancer Treat Rev. 2016 Sep;49:37-44. doi: 10.1016/j.ctrv.2016.07.003. Epub 2016 Jul 12. Cancer Treat Rev. 2016. PMID: 27453294 Review.
Immune Checkpoint Inhibitors and Prostate Cancer: A New Frontier?
Modena A, Ciccarese C, Iacovelli R, Brunelli M, Montironi R, Fiorentino M, Tortora G, Massari F. Modena A, et al. Among authors: iacovelli r. Oncol Rev. 2016 Apr 15;10(1):293. doi: 10.4081/oncol.2016.293. eCollection 2016 Apr 15. Oncol Rev. 2016. PMID: 27471580 Free PMC article. Review.
Wide spetcrum mutational analysis of metastatic renal cell cancer: a retrospective next generation sequencing approach.
Fiorentino M, Gruppioni E, Massari F, Giunchi F, Altimari A, Ciccarese C, Bimbatti D, Scarpa A, Iacovelli R, Porta C, Virinder S, Tortora G, Artibani W, Schiavina R, Ardizzoni A, Brunelli M, Knuutila S, Martignoni G. Fiorentino M, et al. Among authors: iacovelli r. Oncotarget. 2017 Jan 31;8(5):7328-7335. doi: 10.18632/oncotarget.12551. Oncotarget. 2017. PMID: 27741505 Free PMC article.
Cathepsin K expression in castration-resistant prostate carcinoma: a therapeutical target for patients at risk for bone metastases.
Munari E, Cima L, Massari F, Bertoldo F, Porcaro AB, Caliò A, Riva G, Ciocchetta E, Ciccarese C, Modena A, Iacovelli R, Sava T, Eccher A, Ghimenton C, Tortora G, Artibani W, Novella G, Bogina G, Zamboni G, Sanguedolce F, D'Amuri A, Martignoni G, Brunelli M. Munari E, et al. Among authors: iacovelli r. Int J Biol Markers. 2017 May 4;32(2):e243-e247. doi: 10.5301/jbm.5000246. Int J Biol Markers. 2017. PMID: 28085175 Free article.
Prostate cancer heterogeneity: Discovering novel molecular targets for therapy.
Ciccarese C, Massari F, Iacovelli R, Fiorentino M, Montironi R, Di Nunno V, Giunchi F, Brunelli M, Tortora G. Ciccarese C, et al. Among authors: iacovelli r. Cancer Treat Rev. 2017 Mar;54:68-73. doi: 10.1016/j.ctrv.2017.02.001. Epub 2017 Feb 11. Cancer Treat Rev. 2017. PMID: 28231559 Review.
Circulating Tumor Cells: A Reliable Biomarker for Prostate Cancer Treatment Assessment?
Ciccarese C, Montironi R, Fiorentino M, Martignoni G, Brunelli M, Iacovelli R, Lopez-Beltran A, Cheng L, Scarpelli M, Moch H, Tortora G, Massari F. Ciccarese C, et al. Among authors: iacovelli r. Curr Drug Metab. 2017;18(8):692-699. doi: 10.2174/1389200218666170518163549. Curr Drug Metab. 2017. PMID: 28524006 Review.
240 results